Nomura, Motoo http://orcid.org/0000-0002-5967-0610
Kii, Takayuki
Kawada, Junji
Hirota, Masashi
Ohta, Takashi
Matsuyama, Jin
Sakai, Daisuke
Shimokawa, Toshio
Kurokawa, Yukinori
Kawakami, Hisato
Tsujinaka, Toshimasa
Satoh, Taroh
Article History
Received: 14 February 2022
Accepted: 30 May 2022
First Online: 20 June 2022
Declarations
:
: Written informed consent was obtained from all patients. The study was approved by the institutional review board of each institution and was conducted in accordance with the Declaration of Helsinki and was registered in the University Hospital Medical Network Clinical Trials Registry in Japan (UMIN000016830; ExternalRef removed).
: Motoo Nomura, Takayuki Kii, Junji Kawada, Masashi Hirota, Jin Matsuyama, Toshio Shimokawa, and Toshimasa Tsujinaka do not have conflicts of interest to declare and do not have financial or funding support to disclose. Takashi Ohta has received honoraria from Bristol-Myers Squibb, Chugai Pharmaceutical, Teijin Pharma, and Takeda Pharmaceutical, and research funding from Takeda Pharmaceutical. Daisuke Sakai has received honoraria from Chugai Pharmaceutical, and Daiichi Sankyo, research funding from Eli Lilly, scholarship donations from Chugai Pharmaceutical, Ono Pharmaceutical, and Yakult Honsha. Yukinori Kurokawa has received lecture fees from Taiho Pharmaceutical. Hisato Kawakami has received grants from Chugai Pharmaceutical, Eisai, Kobayashi Pharmaceutical, and Taiho Pharmaceutical, consulting fees form Daiichi-Sankyo, honoraria from Bayer Yakuhin, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Eli Lilly Japan, Glaxo Smith Kline, Merck Biopharma, MSD, Ono Pharmaceutical, Otsuka Pharmaceutical, Taiho Pharmaceutical, Takeda Pharmaceutical, Teijin Pharma, and Yakult Pharmaceutical Industry. Taroh Satoh has received honoraria from Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, and Ono Pharmaceutical, research funding from Bei Gene, Chugai Pharmaceutical, MSD, Ono Pharmaceutical, and Yakult Honsha, scholarship donations from Taiho Pharmaceutical, endowed chairs from Chugai Pharmaceutical, Ono Pharmaceutical, and Yakult Honsha.
: All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients before inclusion in the study.